SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Reiji Kojima, Takeo Fujiwara, Akio Matsuda, Masami Narita, Osamu Matsubara, Shigeaki Nonoyama, Yukihiro Ohya, Hirohisa Saito, Kenji Matsumoto, Factors Associated with Steroid Phobia in Caregivers of Children with Atopic Dermatitis, Pediatric Dermatology, 2013, 30, 1
  2. 2
    Winnie K.H. Cheung, Regina L.T. Lee, Children and adolescents living with atopic eczema: an interpretive phenomenological study with Chinese mothers, Journal of Advanced Nursing, 2012, 68, 10
  3. 3
    H. Aubert, S. Barbarot, Non-adhésion et corticothérapie, Annales de Dermatologie et de Vénéréologie, 2012, 139, S7

    CrossRef

  4. 4
    Xi Tan, Steven R Feldman, Jongwha Chang, Rajesh Balkrishnan, Topical drug delivery systems in dermatology: a review of patient adherence issues, Expert Opinion on Drug Delivery, 2012, 9, 10, 1263

    CrossRef

  5. 5
    Esther Hong, Saxon Smith, Gayle Fischer, Evaluation of the Atrophogenic Potential of Topical Corticosteroids in Pediatric Dermatology Patients, Pediatric Dermatology, 2011, 28, 4
  6. 6
    U Blume-Peytavi, U Wahn, Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 5
  7. 7
    H. Aubert-Wastiaux, L. Moret, A. Le Rhun, A.M. Fontenoy, J.M. Nguyen, C. Leux, L. Misery, P. Young, M. Chastaing, N. Danou, P. Lombrail, F. Boralevi, J.P. Lacour, J. Mazereeuw-Hautier, J.-F. Stalder, S. Barbarot, Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency, British Journal of Dermatology, 2011, 165, 4
  8. 8
    Saxon D Smith, Esther Hong, Samantha Fearns, Alex Blaszczynski, Gayle Fischer, Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups, Australasian Journal of Dermatology, 2010, 51, 3
  9. 9
    G. Gupta, P. Mallefet, D.W. Kress, A. Sergeant, Adherence to topical dermatological therapy: lessons from oral drug treatment, British Journal of Dermatology, 2009, 161, 2
  10. 10
    Meghan I Dubina, Jenna L O’Neill, Steven R Feldman, Effect of patient satisfaction on outcomes of care, Expert Review of Pharmacoeconomics & Outcomes Research, 2009, 9, 5, 393

    CrossRef

  11. 11
    B Sigurgeirsson, V Ho, C Ferrándiz, K Andriano, A Grinienko, P Jimenez, Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, 2008, 22, 11
  12. 12
    H. Gollnick, R. Kaufmann, D. Stough, H. Heikkila, K. Andriano, A. Grinienko, P. Jimenez, Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial, British Journal of Dermatology, 2008, 158, 5
  13. 13
    Richard G.B. Langley, Thomas A. Luger, Michael J. Cork, Dirk Schneider, Carle Paul, An Update on the Safety and Tolerability of Pimecrolimus Cream 1%: Evidence from Clinical Trials and Post-Marketing Surveillance, Dermatology, 2007, 215, 1, 27

    CrossRef

  14. 14
    Lawrence F. Eichenfield, Diamant Thaci, Yves de Prost, Lluis Puig, Carle Paul, Clinical Management of Atopic Eczema with Pimecrolimus Cream 1% (Elidel®) in Paediatric Patients, Dermatology, 2007, 215, 1, 3

    CrossRef

  15. 15
    Ulrich R. Hengge, Thomas Ruzicka, Robert A. Schwartz, Michael J. Cork, Adverse effects of topical glucocorticosteroids, Journal of the American Academy of Dermatology, 2006, 54, 1, 1

    CrossRef

  16. 16
    Marianne Grillo, Lee Gassner, Gillian Marshman, Sandra Dunn, Pamela Hudson, Pediatric Atopic Eczema: The Impact of an Educational Intervention, Pediatric Dermatology, 2006, 23, 5
  17. 17
    Jann L??bbe, Sheila F Friedlander, Bernard Cribier, Marie-Anne Morren, Amaro Garc??a-D??ez, Carlo Gelmetti, Heidelore Hofmann, Ronald H Houwing, Stephen Kownacki, Richard G B Langley, Marie Virtanen, Klaus Wolff, Steve Wisseh, Claire McGeown, Beatrice Abrams, Dirk Schneider, Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice, American Journal of Clinical Dermatology, 2006, 7, 2, 121

    CrossRef

  18. 18
    K. L. E. Hon, T. F. Leung, Y. Wong, H. K. So, A. M. Li, T. F. Fok, A survey of bathing and showering practices in children with atopic eczema, Clinical and Experimental Dermatology, 2005, 30, 4
  19. 19
    Kim A. Papp, Thomas Werfel, Regina Fölster-Holst, Jean-Paul Ortonne, Paul C. Potter, Yves de Prost, Miles J. Davidson, Nathalie Barbier, Hans-Peter Goertz, Carle Paul, Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: A two-year study, Journal of the American Academy of Dermatology, 2005, 52, 2, 240

    CrossRef

  20. 20
    Karen Mallin, Melissa Chesler Lazarus, Treating Children Is Different, Dermatologic Clinics, 2005, 23, 2, 171

    CrossRef

  21. 21
    Graham A Thom, Anne R Halbert, Paediatric atopic dermatitis in Perth general practice, Australasian Journal of Dermatology, 2003, 44, 1
  22. 22
    Alexander Kapp, Kim Papp, Ann Bingham, Regina Fölster-Holst, Jean-Paul Ortonne, Paul C. Potter, Wayne Gulliver, Carle Paul, Stephen Molloy, Nathalie Barbier, Mark Thurston, Yves de Prost, Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug, Journal of Allergy and Clinical Immunology, 2002, 110, 2, 277

    CrossRef

  23. 23
    Bruce G Bender, Psychological dysfunction associated with atopic dermatitis, Immunology and Allergy Clinics of North America, 2002, 22, 1, 43

    CrossRef

  24. 24
    Yukihiro Ohya, Hywel Williams, Andrew Steptoe, Hirohisa Saito, Yoji Iikura, Ross Anderson, Akira Akasawa, Psychosocial Factors and Adherence to Treatment Advice in Childhood Atopic Dermatitis, Journal of Investigative Dermatology, 2001, 117, 4, 852

    CrossRef

  25. 25
    C.R. Charman, A.D. Morris, H.C. Williams, Topical corticosteroid phobia in patients with atopic eczema, British Journal of Dermatology, 2000, 142, 5
  26. 26
    A. Y. Finlay, C. H. Smith, General Aspects of Treatment,